Publication Number
WO/2024/028902
Publication Date
08.02.2024
International Application No.
PCT/IN2023/050753
International Filing Date
05.08.2023
Title
[English]
ORAL FORMULATIONS OF ABIRATERONE ACETATE AND METHOD OF MANUFACTURING THEREOF
[French]
FORMULATIONS ORALES D'ACÉTATE D'ABIRATÉRONE ET LEUR PROCÉDÉ DE FABRICATION
Applicants **
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED
407-408, Sharda Chambers, New Marine Lines
Mumbai 400020, Maharashtra, IN
Inventors **
DHARMESH MAHENDRABHAI, Shah
BDR Pharmaceutical International Pvt. Ltd.
“Engineering Centre”
6th Floor, 9, Mathew Road, Opera House
Mumbai 400004, Maharashtra, IN
ARAVIND MANAPPA, Badiger
BDR Research Centre
BDR Pharmaceuticals International Pvt. Ltd.
Survey No. 51/1,51/1/2,51/2,52/2/1,52/2,54/2; AT: Vanseti Village, PO: Tajpura, Taluka: Halol, District: Panchmahals, Gujarat 389350, IN
MUKESHKUMAR SUBHASHCHANDRA, Sharma
BDR Research Centre
BDR Pharmaceuticals International Pvt. Ltd.
Survey No. 51/1,51/1/2,51/2,52/2/1,52/2,54/2; AT: Vanseti Village, PO: Tajpura, Taluka: Halol, District: Panchmahals, Gujarat 389350, IN
MADHAVKUMAR DILIPBHAI, Trivedi
BDR Research Centre
BDR Pharmaceuticals International Pvt. Ltd.
Survey No. 51/1,51/1/2,51/2,52/2/1,52/2,54/2; AT: Vanseti Village, PO: Tajpura, Taluka: Halol, District: Panchmahals, Gujarat 389350, IN
SAMIRKUMAR BABULAL, Panchal
BDR Research Centre
BDR Pharmaceuticals International Pvt. Ltd.
Survey No. 51/1,51/1/2,51/2,52/2/1,52/2,54/2; AT: Vanseti Village, PO: Tajpura, Taluka: Halol, District: Panchmahals, Gujarat 389350, IN
NILAY MANIKANT, Jayaswal
BDR Research Centre
BDR Pharmaceuticals International Pvt. Ltd.
Survey No. 51/1,51/1/2,51/2,52/2/1,52/2,54/2; AT: Vanseti Village, PO: Tajpura, Taluka: Halol, District: Panchmahals, Gujarat 389350, IN
AKSHAYKUMAR SAMPATSINH, Jadav
BDR Research Centre
BDR Pharmaceuticals International Pvt. Ltd.
Survey No. 51/1,51/1/2,51/2,52/2/1,52/2,54/2; AT: Vanseti Village, PO: Tajpura, Taluka: Halol, District: Panchmahals, Gujarat 389350, IN
Priority Data
202221044843
05.08.2022
IN
Application details
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Abstract
[English]
The present invention relates to oral suspension dosage form of Abiraterone Acetate. The invention also relates to provide patient-compliant, economical and technically advanced dosage form over existing dosage form. Moreover, the solubility and stability of the patient compliant Abiraterone Acetate formulation, prepared as per the present invention, is proven higher when compared to prior art inventions. Furthermore, the present invention also provides a suspension composition prepared by a process which is relatively simple, easy to commercially manufacture, and functionally reproducible.
[French]
La présente invention concerne une forme galénique de suspension orale d'acétate d'abiratérone. L'invention concerne également la fourniture d'une forme galénique adaptée au patient, économique et techniquement avancée par rapport à une forme galénique existante. De plus, la solubilité et la stabilité de la formulation d'acétate d'abiratérone adaptée au patient, préparée selon la présente invention, s'avère être plus élevée par rapport aux inventions de l'état de la technique. En outre, la présente invention concerne également une composition de suspension préparée selon un procédé qui est relativement simple, facile à mettre en oeuvre dans le commerce, et fonctionnellement reproductible.